Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage

Neuroscience

Volumn 75, Issue 2, 1996, Pages 345-352

  Perez Navarro E ^a   Arenas, E ^b   Reiriz, J ^a   Calvo, N ^a   Alberch, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; EXCITOTOXIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PARVALBUMIN; QUINOLINIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; FIBROBLAST; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030601657     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00336-3     Document Type: Article

References (36)

1. Arenas E., Pérez-Navarro E., Alberch J., Marsal J. Selective resistance of tachykinin-responsive cholinergic neurons in the quinolinic acid lesioned neostriatum. Brain Res. 603:1993;317-320.
2. Arenas E., Persson H. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature. 367:1994;368-371.
3. Arenas E., Trupp M., Åkerud P., Ibáñez C. F. GDNF prevents the degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron. 15:1995;1465-1473.
4. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
5. Choi-Lundberg D. L., Bohn M. C. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Devl Brain Res. 85:1995;80-88.
6. Cowan R. L., Wilson C. J., Emson P. C., Heizmann C. W. Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J. comp. Neurol. 302:1990;197-205.
7. DiFiglia M., Christakos S., Aronin N. Ultrastructural localization of immunoreactive Calbindin D28K in the rat and monkey basal ganglia, including subcellular distribution with colloidal gold labelling. J. comp. Neurol. 279:1989;653-665.
8. DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 13:1990;286-289.
9. Falkenberg T., Ernfors P., Persson H., Linderfors N. Cortical transynaptic activation of tyrosine kinase receptor trkB messenger RNA expression in rat hippocampus. Neuroscience. 51:1992;883-889.
10. Fearnley J. M., Less A. J. Striatonigral degeneration. Brain. 113:1990;1823-1842.
11. Gerfen C. R., Baimbridge K. G., Miller J. J. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. natn. Acad. Sci. U.S.A. 82:1985;8780-8784.
12. Harrington K. M., Kowall N. W. Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum. J. Neuropath. exp. Neurol. 50:1991;309.
13. Henderson C. E., Phillips H. S., Pollock R. A., Davies A. M., Lemeulle C., Armanini M., Simpson L. C., Moffet B., Vandlen R. A., Koliatsos S. E., Rosenthal A. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 266:1994;1062-1064.
14. Ho A., Gore A. C., Weickert C. S., Blum M. Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. NeuroReport. 6:1995;1326-1330.
15. Humpel C., Hoffer B., Strömberg I., Becktesh S., Collins F., Olson L. Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience. 59:1994;791-795.
16. Kearns C. M., Gash D. M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:1995;104-111.
17. Kiyama H., Seto-Ohshima A., Emson P. C. Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease. Brain Res. 525:1990;209-214.
18. Lin L.-F. H., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
19. Lindvall O., Kokaia Z., Bengzon J., Elmer E., Kokaia M. Neurotrophins and brain insults. Trends Neurosci. 17:1994;490-496.
20. Martin D., Miller G., Rosendahl M., Russell D. A. Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Res. 683:1995;172-178.
21. Mount H. T. J., Dean D. O., Alberch J., Dreyfus C. F., Black I. B. Glial cell line-derived neurotrophic factor (GDNF) promotes the survival and morphological differentiation of Purkinje cells. Proc. natn. Acad. Sci. U.S.A. 92:1995;9092-9096.
22. Oppenheim R. W., Houenou L. J., Johnson J. E., Lin L.-F. H., Li L., Lo A. C., Newsome A. L., Prevette D. M., Wang S. Developing motor neurons rescued from programmed cell death and axotomy-induced cell death by GDNF. Nature. 373:1995;344-346.
23. Pérez-Navarro E., Alberch J., Arenas E., Calvo N., Marsal J. Nerve growth factor and basic fibroblast growth factor protect cholinergic neurons against quinolinic acid excitotoxicity in rat neostriatum. Eur. J. Neurosci. 6:1994;706-711.
24. Poulsen K. T., Armanini M. P., Klein R. D., Hynes M. A., Phillips H. S., Rosenthal A. TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron. 13:1994;1245-1252.
25. Sauer H., Rosenblad C., Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. natn. Acad. Sci. U.S.A. 92:1995;8935-8939.
26. Schaar D. G., Sieber B. A., Dreyfus C. F., Black I. B. Regional and cell-specific expression of GDNF in rat brain. Expl Neurol. 124:1993;368-371.
27. Schmidt-Kastner R., Tomac A., Hoffer B., Becktesh S., Rosenzweig B., Olson L. Glial cell line-derived neurotrophic factor (GDNF) mRNA up-regulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Molec. Brain Res. 26:1994;325-330.
28. Schumacher J. M., Short M. P., Hyman B. T., Breackefield X. O., Isacson O. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience. 45:1991;561-570.
29. Schwarcz R., Whetsell W. O., Mangano R. M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219:1983;316-319.
30. Springer J. E., Mu X., Bergman L. W., Trojanowski J. Q. Expression of GDNF mRNA in rat and human nervous system. Expl Neurol. 127:1994;167-170.
31. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Expl Neurol. 124:1993;401-412.
32. Tomac A., Lindquist E., Lin L.-F. H., Ögren S. O., Young D., Hoffer B. J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
33. Trupp M., Rydén M., Jöurnvall H., Belluardo N., Funakoshi H., Arenas E., Ibáñez C. F. Peripheral expression and biological activities of GDNF, a neurotrophic factor for avian and mammalian sympathetic neurons. J. Cell Biol. 130:1995;137-148.
34. Venero J. L., Beck K. D., Hefti F. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger, but not glutamate decarboxylase, messenger RNA. Neuroscience. 61:1994;257-268.
35. Wenning G. K., Ben-Shlomo Y., Magalhaes M., Daniel S. E., Quinn N. P. Clinicopathological study of 35 cases of multiple system atrophy. J. Neurol. Neurosurg. Psychiat. 58:1995;160-166.
36. Yan Q., Matheson C., Lopez O. T. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature. 373:1995;341-344.